Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,883.00",
    "chg": 0.5,
    "chgp": "0.03%",
    "dir": 1,
    "prev_price": "1,882.50",
    "mcapval": "451,794.77 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "Aug 18, 03:14 PM",
    "curr_time": "15:15 PM",
    "last_traded_at": "Aug 18, 03:14 PM IST",
    "bse_nse_vol": "19.21 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 18, 2026",
    "traded_date_str": "2026 08 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4158834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunPharmaceutic_technicaldot_4158834.png",
        "date": "2026-08-18 08:06:03",
        "description": "Sun Pharmaceutical Industries Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent dip in price, the stock’s underlying technical indicators present a nuanced picture, signalling both resilience and caution for investors navigating the current market environment."
      },
      {
        "title": "P/E at 36.56 vs Industry's 36.60: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-nifty-50-membership-reinforces-market-standing-amid-institutional-shifts-4157376",
        "imagepath": "",
        "date": "2026-08-17 09:21:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Near-Industry P/E Reflecting Market Parity</strong></p>\n                <p>The P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> at 36.56 is almost identical to the sector average of 36.60, indicating that the market currently values the company in line with its peers. This parity suggests that investors are neither assigning a significant premium nor discount relative to the broader Pharmaceuticals & Biotechnology industry. Such a valuation alignment often reflects a consensus view on the company’s earnings prospects and risk profile compared to its sector rivals. However, the subtle difference of 0.04x could be interpreted as a marginally more conservative stance..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-4155101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunPharmaceutic_mojoScore_4155101.png",
        "date": "2026-08-15 10:10:26",
        "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "P/E at 36.9 vs Industry's 36.87: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-4153051",
        "imagepath": "",
        "date": "2026-08-14 09:21:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index confers considerable advantages on Sun Pharmaceutical Industries Ltd, not least in terms of liquidity, visibility, and institutional interest. The Nifty 50 serves as the benchmark for Indian equity markets, representing the largest and most liquid stocks across sectors. Sun Pharma’s inclusion ensures it remains a core holding for index funds, exchange-traded funds (ETFs), and passive investment vehicles, which collectively command substantial capital flows.</p>\n                <p>This membership also elevates the company’s profile among global investors seeking exposure to India’s pharmaceutical and biotechnology sector. The sector itself is a vital component of the Ni..."
      },
      {
        "title": "P/E at 36.75 vs Industry's 36.99: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-4151332",
        "imagepath": "",
        "date": "2026-08-13 09:21:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Close Match to Industry Norms</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.75, marginally below the Pharmaceuticals & Biotechnology industry average of 36.99. This near equivalence suggests that the market is pricing the stock in line with its sector peers, reflecting neither a significant premium nor a discount. Such valuation alignment often indicates that investors are factoring in the company’s fundamentals and growth prospects similarly to the broader industry. However, the subtle difference could also imply slight caution or optimism depending on other performance metrics and market sentiment. <a href=\"h..."
      },
      {
        "title": "P/E at 36.84 vs Industry's 36.87: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-nifty-50-membership-reinforces-market-standing-amid-institutional-shifts-4149636",
        "imagepath": "",
        "date": "2026-08-12 09:21:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Near-Industry P/E Reflects Balanced Market View</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.84, almost identical to the Pharmaceuticals & Biotechnology industry average of 36.87. This near-equal valuation suggests that the market neither applies a significant premium nor a discount to the stock relative to its peers. Such parity often indicates that investors are pricing in the company’s fundamentals and growth prospects in line with sector expectations. However, this equilibrium also means that any deviation in earnings or sector dynamics could quickly shift the stock’s relative attractiveness. <a href=\"https:..."
      },
      {
        "title": "P/E at 37.08 vs Industry's 36.59: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-4146875",
        "imagepath": "",
        "date": "2026-08-11 09:21:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium but in Line with Industry</strong></p>\n                <p>The current P/E of 37.08 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> sits slightly above the Pharmaceuticals &amp; Biotechnology industry average of 36.59. This premium, though not excessive, suggests that investors are willing to pay a marginally higher price for the company’s earnings relative to its peers. Such a valuation often reflects expectations of stable earnings growth or superior business fundamentals. However, the premium is narrow enough to warrant scrutiny — <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharma</a> is not trading at a valuatio..."
      },
      {
        "title": "P/E at 37.01 vs Industry's 36.63: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-nifty-50-membership-and-institutional-dynamics-shape-market-outlook-4144904",
        "imagepath": "",
        "date": "2026-08-10 09:21:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Slight Premium Reflecting Sector Alignment</strong></p>\n                <p>The P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> at 37.01 is just a fraction above the sector average of 36.63, indicating that the stock is valued broadly in line with its peers. This modest premium suggests that investors are pricing in steady earnings growth or a relatively stable outlook compared to the broader Pharmaceuticals &amp; Biotechnology industry. The sector itself is characterised by a mix of growth and defensive qualities, which is reflected in the balanced P/E levels.</p>\n                <p>Given this valuation context, <a href=\"https://www.marketsmojo.com/stocks-analysis/..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Declines 2.03% Amid Put Option Surge and Valuation Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-declines-203-amid-put-option-surge-and-valuation-shift-4143270",
        "imagepath": "",
        "date": "2026-08-08 14:07:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Heavy put option activity amid bearish hedging</p>\n                    <p><strong>4 Aug:</strong> Valuation shift from very expensive to expensive</p>\n                    <p><strong>7 Aug:</strong> Week closes at ₹1,949.00 (-2.03%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,989.35</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹1,949.00</div><div class=\"stat-change negative\">-2.03%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Wee..."
      }
    ],
    "total": 1246,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "06-Aug-2026",
      "details": "Q1FY27 Earnings Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Receipt Of No-Objection Letters From The Stock Exchanges For Reclassification Of Promoter Group",
      "datetime": "06-Aug-2026",
      "details": "Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "05-Aug-2026",
      "details": "Update on Credit Rating",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26",
          "dt": "2026-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-08-18 08:06:03

Sun Pharmaceutical Industries Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent dip in price, the stock’s underlying technical indicators present a nuanced picture, signalling both resilience and caution for investors navigating the current market environment.

Read full news article

P/E at 36.56 vs Industry's 36.60: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-17 09:21:01

Valuation Picture: A Near-Industry P/E Reflecting Market Parity

The P/E ratio of Sun Pharmaceutical Industries Ltd at 36.56 is almost identical to the sector average of 36.60, indicating that the market currently values the company in line with its peers. This parity suggests that investors are neither assigning a significant premium nor discount relative to the broader Pharmaceuticals & Biotechnology industry. Such a valuation alignment often reflects a consensus view on the company’s earnings prospects and risk profile compared to its sector rivals. However, the subtle difference of 0.04x could be interpreted as a marginally more conservative stance...

Read full news article

Sun Pharmaceutical Industries Ltd is Rated Buy

2026-08-15 10:10:26

Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

P/E at 36.9 vs Industry's 36.87: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-14 09:21:07

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index confers considerable advantages on Sun Pharmaceutical Industries Ltd, not least in terms of liquidity, visibility, and institutional interest. The Nifty 50 serves as the benchmark for Indian equity markets, representing the largest and most liquid stocks across sectors. Sun Pharma’s inclusion ensures it remains a core holding for index funds, exchange-traded funds (ETFs), and passive investment vehicles, which collectively command substantial capital flows.

This membership also elevates the company’s profile among global investors seeking exposure to India’s pharmaceutical and biotechnology sector. The sector itself is a vital component of the Ni...

Read full news article

P/E at 36.75 vs Industry's 36.99: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-13 09:21:19

Valuation Picture: A Close Match to Industry Norms

The current P/E of Sun Pharmaceutical Industries Ltd stands at 36.75, marginally below the Pharmaceuticals & Biotechnology industry average of 36.99. This near equivalence suggests that the market is pricing the stock in line with its sector peers, reflecting neither a significant premium nor a discount. Such valuation alignment often indicates that investors are factoring in the company’s fundamentals and growth prospects similarly to the broader industry. However, the subtle difference could also imply slight caution or optimism depending on other performance metrics and market sentiment. Read full news article

P/E at 36.84 vs Industry's 36.87: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-12 09:21:40

Valuation Picture: Near-Industry P/E Reflects Balanced Market View

The current P/E of Sun Pharmaceutical Industries Ltd stands at 36.84, almost identical to the Pharmaceuticals & Biotechnology industry average of 36.87. This near-equal valuation suggests that the market neither applies a significant premium nor a discount to the stock relative to its peers. Such parity often indicates that investors are pricing in the company’s fundamentals and growth prospects in line with sector expectations. However, this equilibrium also means that any deviation in earnings or sector dynamics could quickly shift the stock’s relative attractiveness. Read full news article

P/E at 37.08 vs Industry's 36.59: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-11 09:21:02

Valuation Picture: Premium but in Line with Industry

The current P/E of 37.08 for Sun Pharmaceutical Industries Ltd sits slightly above the Pharmaceuticals & Biotechnology industry average of 36.59. This premium, though not excessive, suggests that investors are willing to pay a marginally higher price for the company’s earnings relative to its peers. Such a valuation often reflects expectations of stable earnings growth or superior business fundamentals. However, the premium is narrow enough to warrant scrutiny — Sun Pharma is not trading at a valuatio...

Read full news article

P/E at 37.01 vs Industry's 36.63: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-10 09:21:26

Valuation Picture: Slight Premium Reflecting Sector Alignment

The P/E ratio of Sun Pharmaceutical Industries Ltd at 37.01 is just a fraction above the sector average of 36.63, indicating that the stock is valued broadly in line with its peers. This modest premium suggests that investors are pricing in steady earnings growth or a relatively stable outlook compared to the broader Pharmaceuticals & Biotechnology industry. The sector itself is characterised by a mix of growth and defensive qualities, which is reflected in the balanced P/E levels.

Given this valuation context, Read full news article

Sun Pharmaceutical Industries Ltd Declines 2.03% Amid Put Option Surge and Valuation Shift

2026-08-08 14:07:11

Key Events This Week

3 Aug: Heavy put option activity amid bearish hedging

4 Aug: Valuation shift from very expensive to expensive

7 Aug: Week closes at ₹1,949.00 (-2.03%)

Week Open

₹1,989.35

Week Close

₹1,949.00

-2.03%

Wee...

Read full news article

View All News